Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Change in Inventory (2024 - 2025)

Syndax Pharmaceuticals (SNDX) has 2 years of Change in Inventory data on record, last reported at $7.8 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 2031.42% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $32.1 million, up 8668.03%, while the annual FY2025 figure was $32.1 million, 8668.03% up from the prior year.
  • Change in Inventory reached $7.8 million in Q4 2025 per SNDX's latest filing, up from $7.2 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $12.9 million in Q2 2025 and bottomed at $366000.0 in Q4 2024.